Prevention of migraine in women throughout the life span

Beverly S. Tozer, Elizabeth A. Boatwright, Paru S. David, Deepa P. Verma, Janis E. Blair, Anita P. Mayer, Julia A. Files

Research output: Contribution to journalReview article

6 Scopus citations

Abstract

Migraine is a common disorder in women. The 1-year prevalence of migraine is 18% in women compared with 6% in men. Migraine most commonly occurs during the reproductive years, affecting 27% of women 30 to 49 years of age. The predominance of this disorder and its social, functional, and economic consequences make migraine an important issue in women's health. The hormonal milieu has a substantial effect on migraine in women. An understanding of these hormonal influences in the various stages of life in females is essential to the management and prevention of migraines. This article reviews migraine prevention strategies with an emphasis on specific therapies for each stage of a woman's life.

Original languageEnglish (US)
Pages (from-to)1086-1092
Number of pages7
JournalMayo Clinic proceedings
Volume81
Issue number8
DOIs
StatePublished - Aug 2006

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Prevention of migraine in women throughout the life span'. Together they form a unique fingerprint.

  • Cite this

    Tozer, B. S., Boatwright, E. A., David, P. S., Verma, D. P., Blair, J. E., Mayer, A. P., & Files, J. A. (2006). Prevention of migraine in women throughout the life span. Mayo Clinic proceedings, 81(8), 1086-1092. https://doi.org/10.4065/81.8.1086